Browsing by Author Carter, Candace

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2013BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III MelanomaCampain, Anna; Carter, Candace; De Silva, Chitra; Gerega, Sebastien; Hersey, Peter; Kefford, Richard (Rick); Lai, Kenneth; Mann, Graham; Pianova, Svetlana; Pupo, Gulietta; Schramm, Sarah-Jane; Scolyer, Richard; Synnott, Catherine; Thompson, John; Wilmott, James; Yang, Yee (Jean); Mathematics & Statistics; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Melanoma Foundation; Biological Sciences; Northern Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Clinical Ophthal & Eye Health; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: Pathology; RADS - Research Analytics & Data Strategy; Central Clinical School: Surgery; Central Clinical School: Surgery; Mathematics & StatisticsBRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma, The Journal of Investigative Dermatology, vol.133, 2, 2013,pp 509-517
2007Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.Beale, Philip; Carter, Candace; Dhillon, Haryana; Heritier, Stephane; Hickie, Ian; O'Connell, Rachel; Simes, Robert John; Stockler, Martin; Wilcken, Nicholas; Abdi, Ehtesham A; Glasgow, Amanda; Goldstein, David; Jefford, Michael; Nowak, Anna K.; Turner, Jane; Wyld, David; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Brain & Mind Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial., Lancet Oncology, vol.8,(7),2007,pp 603-612
2012A high-throughput panel for identifying clinically relevant mutation profiles in melanomaCarter, Candace; Mann, Graham; Pupo, Gulietta; Scolyer, Richard; Tembe, Varsha; Aoude, Lauren G; Dutton-Regester, Ken; et al, various; Hunt, Priscilla; Irwin, Darryl; Lanagan, Cathy; O'Connor, Linda; O'Rourke, Michael; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)A high-throughput panel for identifying clinically relevant mutation profiles in melanoma, Molecular Cancer Therapeutics, vol.11, 4, 2012,pp 888-897
2012Identification of TFG (TRK-Fused Gene) as a Putative Metastatic Melanoma Tumor Suppressor GeneMann, Graham; Pupo, Gulietta; Scolyer, Richard; Tembe, Varsha; Aoude, Lauren G; Carter, Candace; Dutton-Regester, Ken; et al, various; Lanagan, Cathy; Nancarrow, Derek J.; O'Connor, Linda; O'Rourke, Michael; Stark, Mitchell; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)Identification of TFG (TRK-Fused Gene) as a Putative Metastatic Melanoma Tumor Suppressor Gene, Genes Chromosomes and Cancer, vol.51, 5, 2012,pp 452-461